Objectives Defects in regulatory T cell (Treg) biology have been associated with human
systemic autoimmune diseases, such as systemic lupus erythematosus (SLE). However, the …

COVID-19 shares the feature of autoantibody production with systemic autoimmune diseases.
In order to understand the role of these immune globulins in the pathogenesis of the …

The origins and consequences of a regulatory T cell (Treg) disorder in systemic lupus
erythematosus (SLE) are poorly understood. In the (NZBxNZW) F 1 mouse model of lupus, we …

… Jens Y Humrich1, … Correspondence to Dr Jens Y Humrich, Department of Rheumatology
and Clinical Immunology, Charité—University Medicine Berlin, Charitéplatz 1, Berlin 10117, …

Regulatory T cells (Treg) are crucial for the maintenance of peripheral tolerance and for the
control of ongoing inflammation and autoimmunity. The cytokine interleukin-2 (IL-2) is …

Autoantibodies have been associated with autoimmune diseases. However, studies have
identified autoantibodies in healthy donors (HD) who do not develop autoimmune disorders. …

Approximately 5% of the world-wide population is affected by autoimmune diseases. Overall,
autoimmune diseases are still difficult to treat, impose a high burden on patients, and have …

The basic helix-loop-helix transcriptional repressor twist1, as an antagonist of nuclear factor
κB (NF-κB)–dependent cytokine expression, is involved in the regulation of inflammation-…

… Rudolf Manz Rudolf Manz 2 Jens Y. Humrich Jens Y. Humrich 1 Relana Nieberding Relana
Nieberding 1 Gabriela Riemekasten Gabriela Riemekasten 1 Antje Müller\r\n Antje Müller 1 …

Objectives A regulatory T cell (Treg) insufficiency due to shortage of interleukin-2 (IL-2) is
central to the pathophysiology of systemic lupus erythematosus (SLE). We performed a …